<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>363</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15259019</PubmedId>
            <Abstract>The 16-kDa protein of Mycobacterium tuberculosis represents an important antigenic target during bacillary latency and, consequently, should be considered as candidate subunit vaccine component. In this study, we have used CD4 T cell clones that recognize the peptide p91-110, an immunodominant and genetically permissive epitope, in the context of five different HLA-DR molecules and truncated and substituted variants of this peptide, to identify the minimal binding sequence (HLA-DR-binding core) and the minimal stimulatory sequence (TCR-binding core), as well as the residues that contact HLA-DR molecules and the TCR. We have found a common 9-mer sequence, spanning amino acids 93-101, as the binding core for HLA-DR1, -DR11, -DR13 and -DR7, but a longer (13-mer) sequence spanning amino acids 92-104 was required for binding to the HLA-DR15 molecules. F(93) was required for binding to all the tested HLA-DR molecules, hence allowing us to identify it as the N-terminal primary anchor residue (P1). Additionally, the binding requirements for other residues varied considerably between the tested alleles: A(94) for HLA-DR15, V(99) for HLA-DR1, -DR15, -DR11 and -DR7, R(100) for HLA-DR11 and -DR13, and L(104) for HLA-DR15. Concerning the residues of p91-110 peptide required for binding to the TCR, the pepscan analysis results would support the contention that P(-1) E(92), P6 F(98) would be important TCR contact sites because their substitutions led to full loss of T cell activation. Moreover, P8 R(100) is found to be critical residue in binding to HLA-DR11- and -DR13-restricted T cell clones, without influencing binding to the relevant HLA-DR molecule. Our results could be useful to design peptides with altered HLA anchor residues or TCR interaction sites to achieve remarkable increase in activity and to study their vaccine potential.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>2220-9</ArticlePages>
            <ArticleTitle>Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Caccamo</LastName>
                    <ForeName>Nadia</ForeName>
                </Author>
                <Author>
                    <LastName>Meraviglia</LastName>
                    <ForeName>Serena</ForeName>
                </Author>
                <Author>
                    <LastName>La Mendola</LastName>
                    <ForeName>Carmela</ForeName>
                </Author>
                <Author>
                    <LastName>Bosze</LastName>
                    <ForeName>Szylvia</ForeName>
                </Author>
                <Author>
                    <LastName>Hudecz</LastName>
                    <ForeName>Ferencz</ForeName>
                </Author>
                <Author>
                    <LastName>Ivanyi</LastName>
                    <ForeName>Juraj</ForeName>
                </Author>
                <Author>
                    <LastName>Dieli</LastName>
                    <ForeName>Francesco</ForeName>
                </Author>
                <Author>
                    <LastName>Salerno</LastName>
                    <ForeName>Alfredo</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Biopathology, University of Palermo, Corso Tukory 211, I-90134 Palermo, Italy.</Affiliations>
            <ArticleChemicalList>Bacterial Proteins;HLA-DR Antigens;Peptides;Receptors, Antigen, T-Cell</ArticleChemicalList>
            <ArticleMeshHeadingsList>Bacterial Proteins(immunology); HLA-DR Antigens(immunology); Humans; Mycobacterium tuberculosis(immunology); Peptides(immunology); Receptors, Antigen, T-Cell(immunology); T-Lymphocytes(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>34</Volume>
                <Issue>8</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57415</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 5 and 6</LocationOfData>
                        <TCellId>485</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>B1.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>350</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to the epitope by releasing IFN-g, residues 92 Glu, 93 Phe, 98 Phe, and 99 Val played important roles in the response, because their substitutions led to full loss of T cell activation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851167</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>B2.1</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>336</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-110) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851168</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>B2.1</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>336</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>92</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B8.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragments (92-110 and 92-104) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851262</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P4.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>333</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-110) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851072</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P6.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>327</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-110) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851073</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P6.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>327</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>92</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B8.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragments (92-110 and 92-104) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 5 and 6</LocationOfData>
                        <TCellId>482</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>B2.1</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>336</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to the epitope by releasing IFN-g, residues 92 Glu, 93 Phe, 94 Ser, 98 Phe, and 99 Val, 104 Leu played important roles in the response, because their substitutions led to full loss of T cell activation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851263</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P4.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>333</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVS</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>103</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B8.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-103) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851264</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>B1.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>350</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-110) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 5 and 6</LocationOfData>
                        <TCellId>481</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P6.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>327</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to the epitope by releasing IFN-g, residues 92 Glu, 93 Phe, 98 Phe, and 99 Val played important roles in the response, because their substitutions led to full loss of T cell activation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 5 and 6</LocationOfData>
                        <TCellId>483</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P5.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>330</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to the epitope by releasing IFN-g, residues 92 Glu, 93 Phe, 98 Phe, 99 Val, 100 Arg played important roles in the response, because their substitutions led to full loss of T cell activation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 5 and 6</LocationOfData>
                        <TCellId>484</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P4.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>333</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>104</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to the epitope by releasing IFN-g, residues 92 Glu, 93 Phe, 98 Phe, and 100 Arg played important roles in the response, because their substitutions led to full loss of T cell activation.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851169</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P5.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>330</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B7.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-110) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 5</LocationOfData>
                        <TCellId>1851170</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:399</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Mycobacterium tuberculosis</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD4+</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                                            <StartingPosition>91</StartingPosition>
                                            <EndingPosition>104</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P0A5B7.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The TB patients were diagnosed by ultrasound, CT scanning and symptomatic improvement following anti-TB chemotherapy. M. tuberculosis was detected by culture and by polymerase chain reaction (PCR) in both cerebrospinal fluids samples (patients 4 and 5) and pleural fluid sample (patient 1). Two patients were affected by TB pleuritis, one by effusive TB pericarditis and the other two by TB meningitis. All five patients had a negative tuberculin-PPD skin test with X 5 mm skin induration at 48â€“72 h after injection of 1 U of PPD. None of the patients had evidence of HIV infection, nor were treated with steroids or anti-TB drugs at the time of first sampling.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>P5.2</AssayedTcrMoleculeName>
                            <AssayTcrMoleculeChain1Type>Alpha</AssayTcrMoleculeChain1Type>
                            <AssayTcrMoleculeChain2Type>Beta</AssayTcrMoleculeChain2Type>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>330</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFAYGSFVRTVS</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>103</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P0A5B8.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope specific T cell clone responded to fragment (91-103) of 16-kDa protein of M. tuberculosis by releasing IFN-g.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <MhcBindingId>474</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <MhcBindingId>476</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <MhcBindingId>477</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <MhcBindingId>475</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <MhcBindingId>478</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTVSLPVGADE</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57417</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17865</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17868</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17869</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17867</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6300.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17866</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-103</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTVS</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>103</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57413</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17877</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17879</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4400.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17876</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17878</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17880</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4500.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-102</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTV</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>102</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57411</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17881</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17883</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>9000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17882</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17884</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17885</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-101</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVRT</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>101</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57409</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17886</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17890</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17889</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17888</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6200.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17887</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-100</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFAYGSFVR</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>57407</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17894</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17892</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17893</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17895</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17891</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p92-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EFAYGSFVRTVSLPVGADE</LinearSequence>
                        <StartingPosition>92</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>11951</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17896</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17900</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17898</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17897</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4500.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17899</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p93-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FAYGSFVRTVSLPVGADE</LinearSequence>
                        <StartingPosition>93</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>15310</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17902</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17904</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17905</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17901</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5500.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17903</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p94-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AYGSFVRTVSLPVGADE</LinearSequence>
                        <StartingPosition>94</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>5790</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17910</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17906</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17907</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17908</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17909</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p95-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YGSFVRTVSLPVGADE</LinearSequence>
                        <StartingPosition>95</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>74080</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17911</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17914</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17912</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17915</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17913</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p92-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EFAYGSFVRTVSL</LinearSequence>
                        <StartingPosition>92</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>11950</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17918</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17919</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17920</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5200.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17916</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6200.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17917</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p93-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FAYGSFVRTVSL</LinearSequence>
                        <StartingPosition>93</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>15308</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17923</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17925</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6400.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17921</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17922</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17924</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p94-104</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AYGSFVRTVSL</LinearSequence>
                        <StartingPosition>94</StartingPosition>
                        <EndingPosition>104</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>5789</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17928</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17929</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17930</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17927</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17926</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p93-101</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FAYGSFVRT</LinearSequence>
                        <StartingPosition>93</StartingPosition>
                        <EndingPosition>101</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P0A5B7.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>15307</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17935</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8400.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17934</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7200.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17931</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17932</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>17933</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 S&lt;sup&gt;91&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AEFAYGSFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>900</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271737</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271735</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271733</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271736</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271734</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 E&lt;sup&gt;92&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SAFAYGSFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>56770</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271739</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>18000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271742</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>12000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271741</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271738</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271740</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>210000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 F&lt;sup&gt;93&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEAAYGSFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57348</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271753</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271751</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271754</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271750</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271752</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 A&lt;sup&gt;94&lt;/sup&gt;-S</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFSYGSFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57434</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271777</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>28000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271778</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>14000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271779</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>14700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271776</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>56000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271775</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 Y&lt;sup&gt;95&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAAGSFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57401</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271789</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271788</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>36000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271787</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271785</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271786</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 G&lt;sup&gt;96&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYASFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57402</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271793</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>9000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271792</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271795</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271796</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271794</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 S&lt;sup&gt;97&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGAFVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57403</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271798</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271801</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6500.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271802</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6300.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271799</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271800</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 F&lt;sup&gt;98&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSAVRTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57404</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271814</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>16000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271811</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>24000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271810</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>14000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271812</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>13000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271813</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>12000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 V&lt;sup&gt;99&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFARTVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57405</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271821</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271820</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271819</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271817</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271818</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 R&lt;sup&gt;100&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFVATVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57406</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271826</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271824</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271825</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271828</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271827</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6300.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 T&lt;sup&gt;101&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFVRAVSL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57408</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271833</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5500.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271831</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6300.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271830</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7100.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271832</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6900.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271834</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 V&lt;sup&gt;102&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTASL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57410</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271841</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4400.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271843</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>6700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271842</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4400.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271844</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7700.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271840</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 S&lt;sup&gt;103&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTVAL</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57412</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271850</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>8000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271853</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>46000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271854</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>64000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271852</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271851</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M. tuberculosis p91-104 L&lt;sup&gt;104&lt;/sup&gt;-A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>SEFAYGSFVRTVSA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>SEFAYGSFVRTVSL</LinearSequence>
                            <StartingPosition>91</StartingPosition>
                            <EndingPosition>104</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P0A5B8.2</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>1773</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>57414</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271855</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>336</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271858</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7800.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>350</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271857</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>7600.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>327</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271859</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>9000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>333</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1271856</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>273</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>The binding affinity of the epitope was calculated as the concentration of competitor peptide required to inhibit 50% of the binding of an allele-specific biotinylated peptide (CLIP).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>330</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

